Day: March 31, 2025

Isomorphic Labs, a pioneering AI-driven drug discovery firm and an Alphabet subsidiary, has ignited fresh waves across both the artificial intelligence and pharmaceutical landscapes with its recent $600 million funding announcement. Unveiled in April 2024, the funding aims to accelerate the development of Isomorphic Labs’ next-generation platform for AI-based drug design and to push forward…